chromatin decondensation, 8 likely driven by lamin dysfunction. 9 Recent studies now show that fly models expressing R 406 W tau also have an increase in the transposable element transcripts. 10, 11 Similar observations have been made in a Drosophila TDP-43 model, in which retrotransposon transcripts are increased and appear to contribute to pathology. 12 Although the cause of increased retrotransposon expression in various neurodegeneration models is unclear, Sun et al 10 showed that expression of R 406 W tau reduced the abundance of PIWI-interacting RNAs (piRNAs) targeting retrotransposons. In addition, knockdown of the piRNA-specific Argonaute protein PIWI was synthetic lethal within the context of transgenic tau expression, supporting the view that piRNAs are a causal mediator of neuronal death in tauopathy. Considering that the recruitment of HP1 can be facilitated by piRNAs, it is possible that piRNA dysfunction/repression is a major contributor to RE-mediated neuronal death in multiple forms of neurodegeneration. Whether TDP-43-opathies also disrupt piRNAs is an open question.
Multiple lines of evidence suggest that the chromatin changes and increased accumulation of repetitive element transcripts identified in the invertebrate models also occur in the associated neurodegenerative diseases. Repetitive element transcripts are increased in the brains of ALS patients, in particular in patients with an expansion of the C9orf72 hexanucleotide repeat. 13 Increases in the endogenous retroviral class of transposable elements have been observed in the brains of Alzheimer disease (AD) patients 11, 12 as has increased expression of genes usually silenced by heterochromatin. 8 Although it has been reported that long interspersed nuclear elements (LINE) transcripts do not increase in the AD, 14 our reanalysis ( Figure 2A ) of published RNA-seq (global transcriptome
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analysis high-throughput sequencing) data 15 from AD patients and controls is consistent with increased levels of transcripts from multiple classes of repetitive elements, including LINEs, short interspersed nuclear elements (SINEs), and satellite sequences. Interestingly, analysis of this data also reveals an increase in the adenosine-to-inosine RNA editing, a post-transcriptional modification of transcripts that only occurs on dsRNA ( Figure 2B) .
Unresolved is the degree to which heterochromatin changes and increased levels of repetitive element transcripts contribute to disease-relevant pathology. Long interspersed nuclear element 1 (LINE-1) can undergo somatic transposition in neuronal precursor cells, 16 and therefore, the increased levels of retrotransposon transcripts in ALS and AD patient brains could lead to transposition events that alter gene expression and/or induce a DNA damage response. However, identification and quantification of transposition events in patient samples is technically challenging, and has not been directly demonstrated in neurodegenerative diseases. Alternatively, as repetitive element transcripts can form both intrastrand (eg, from inverted repeats of Alu elements in 3′ untranslated regions [UTRs]) and interstrand (eg, from complementary base-pairing of LINEs transcribed from opposite strands) dsRNA, the increased repetitive element transcripts in ALS and AD could lead to an increase in cytoplasmic dsRNA. As dsRNA is a classic inducer of interferon and anti-viral innate immune responses, increased dsRNA from endogenous transcripts could lead to inappropriate, and potentially pathogenic, immune responses. Indeed, accumulation of dsRNA composed of Alu sequences has been claimed to underlie geographic atrophy, an untreatable advanced form of age-related macular degeneration that results from degeneration of retinal pigmented epithelium cells. 17 Very recently, a study from the Albers lab 18 has demonstrated that transgenic expression of dsRNA in mice can directly induce central nervous system (CNS) neurodegeneration. In addition, these investigators provide evidence that dsRNA can be specifically detected in the brains of familial ALS patients containing the C9orf72 hexanucleotide expansion, which we believe to be the first direct demonstration of increased dsRNA in a neurodegenerative disease.
If our hypotheses concerning neurodegeneration, heterochromatin, and dsRNA are correct, we anticipate that accumulation of dsRNA will be discovered in additional neurodegenerative conditions, including AD. Furthermore, we would predict that treatments that block heterochromatin derepression or dsRNA-induced innate immune activation will ameliorate the neuroinflammation associated with neurodegenerative 
